CVE-2020-11973

Description

Apache Camel Netty enables Java deserialization by default. Apache Camel 2.22.x, 2.23.x, 2.24.x, 2.25.0, 3.0.0 up to 3.1.0 are affected. 2.x users should upgrade to 2.25.1, 3.x users should upgrade to 3.2.0.

Category

9.8
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 2.0 •
EPSS 9.48% Top 10%
Vendor Advisory apache.org
Affected: n/a Apache Camel
Published at:
Updated at:

References

Link Tags
http://www.openwall.com/lists/oss-security/2020/05/14/9 third party advisory mailing list
https://www.oracle.com/security-alerts/cpuoct2020.html third party advisory
https://camel.apache.org/security/CVE-2020-11973.html vendor advisory
https://www.oracle.com/security-alerts/cpujan2021.html third party advisory
https://www.oracle.com/security-alerts/cpuApr2021.html third party advisory
https://www.oracle.com//security-alerts/cpujul2021.html third party advisory

Frequently Asked Questions

What is the severity of CVE-2020-11973?
CVE-2020-11973 has been scored as a critical severity vulnerability.
How to fix CVE-2020-11973?
To fix CVE-2020-11973, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-11973 being actively exploited in the wild?
It is possible that CVE-2020-11973 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~9% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-11973?
CVE-2020-11973 affects n/a Apache Camel.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.